No spam - just the good stuff
Subscribe to our newsletter
First Name
(Required)
Email Address
(Required)
Hidden
Contact Source
News
Investment
Lifestyle
Videos
Search for:
Search
More
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
Indication expansion
New Buck Institute study is treasure trove for longevity research
Indication expansion
Gerostate Alpha: “Our phenotype is lifespan”
Indication expansion
Drusolv targets macular degeneration with statin therapy
Drusolv seeks $2 million to prepare IND application for repurposed statin for treatment of AMD ahead of Phase 2 trials.
Indication expansion
“The major modulators of aging remain to be discovered”
Indication expansion
A year in Longevity: progress perspectives
Indication expansion
A year in Longevity: different perspectives
Indication expansion
Longevity biomarker firm to align CROs, pharma and consumers
Indication expansion
Eliminating senescent cells to improve heart attack recovery
Indication expansion
Calico’s memory-enhancing drug reverses age-related mental decline
Indication expansion
BioAge CEO: “It’s all about the data.”
Indication expansion
BioAge lands $90 million; gears up for clinical trials in 2021
Indication expansion
AgelessRx and funding an IRB-approved rapamycin trial
Indication expansion
COVID-19: Leading clinician calls for focus on the biology of aging
Indication expansion
Inflammaging – could ibuprofen be the answer?
Indication expansion
Peptide molecule causes cancer cells to self destruct
Indication expansion
Using small data to target Alzheimer’s
Indication expansion
Combining existing medicines to target aging
Indication expansion
Reproductive Longevity – taking the geroscience approach
Indication expansion
Longevity-extending compounds key to neurodegenerative treatment
Indication expansion
The metformin debate swings both ways
Indication expansion
$2m Longevity boost for rapamycin Alzheimer’s study
Indication expansion
GlobalData finds AI accelerates drug repurposing
Indication expansion
FDA approval for small molecule drug bodes well for Longevity
Indication expansion
Fruit fly research could hold key to lifespan
Indication expansion
Exploring the neuroprotective benefits of Longevity drug candidates
Indication expansion
Challenging the one drug/one disease model
Indication expansion
Fountain’s ‘hypothesis-free’ approach to Longevity AI
Indication expansion
Applying theoretical physics to Longevity drug discovery
Indication expansion
Longevity and the art of motorcycle maintenance
Indication expansion
BioAge licenses HIF-PH inhibitor to treat aging
Indication expansion
Longevity2020: Day 3 recap
Indication expansion
Building faster and better age-related clinical trials
Indication expansion
Load More